Can LRCX Stock Live Up To Its Multiple?
Lam Research (LRCX) stock trades at $296.05 per share, a market cap of $370.0B, and 55.2x trailing PE. That is a premium. The question is not whether the stock is “cheap” or “expensive” in the abstract – it is what the market is implicitly assuming about the business to justify paying this price.
Where LRCX Stands Today
- Valuation: P/E of 55.2 versus a 3-year average of 26.7 and a 3-year high of 55.2.
- Revenue: Revenue grew 26.5% over the last 12 months, with a 3-year CAGR of 7.5%.
- Net Margin: Running at 30.9% LTM, against a 3-year average of 27.0% and a 3-year peak of 30.9%.
The table below summarizes the same picture, but it helps to have a LRCX’s deeper understanding of full financial trajectory.
| LRCX | |
|---|---|
| Sector | Information Technology |
| Industry | Semiconductor Materials & Equipment |
| P/E Ratio | 55.2 |
| P/E Ratio 3Y Avg | 26.7 |
| LTM* Revenue Growth | 26.5% |
| 3Y Avg Revenue Growth | 7.5% |
| LTM* Net Margin | 30.9% |
| 3Y Peak Net Margin | 30.9% |
| 3Y Avg Net Margin | 27.0% |
*LTM: Last Twelve Months
- Is the Arista Rally Over? The Path to $111
- Get Paid 12% To Buy AVGO At A 30% Discount – Here’s How
- Is United Rentals Stock Utilizing Systematic Share Retirement for Long-Term Alpha?
- Micron Stock Surged 9x But History Suggests Caution.
- Does Exxon Mobil Stock Still Have Room to Run?
- Is Royal Caribbean Stock Undervalued Stock Or Value Trap?
Working Backwards From The Price
A 55.2x multiple is not a forecast on its own – it is a claim. It says the business will be substantially bigger or more profitable than it is today, by a large enough margin to justify the premium even after the multiple itself normalizes. Reverse-engineering that claim takes three judgments:
- How long does the market give it? Faster growth and a richer multiple buy more runway. For LRCX, we work with a 4-year horizon considering a moderate premium with strong growth.
- What is a fair mature multiple? Once growth normalizes, the stock should re-rate toward something close to the kind of multiple a mature, profitable tech/semis business typically settles into. Blended with LRCX’s own 3-year average, we land at 25.7x.
- What about margins? Margin is currently expanding versus the 3-year average; we assume it will approach recent peak levels, settling around 30.3%.
Lock those three in, and the revenue path the market is implicitly demanding falls out as arithmetic.
The Implied Math: What Growth & Size Market Is Pricing In
A straightforward back-calculation, not a forecast.
- Today: LRCX is valued at $370.0B on $6.7B of LTM net income, a P/E of 55.2.
- In 4 years, we estimate the P/E settles at 25.7x – the kind of multiple a mature, profitable tech/semis business typically settles into.
- Holding the valuation flat at today’s $370.0B, that multiple compression requires net income to reach $14.4B, roughly 115% above today’s base. That is a 21.1% annual earnings CAGR over the next 4 years.
- Net Margin at maturity: 30.3%. Today’s margin is 30.9%; the 3-year average is 27.0% and the 3-year peak is 30.9%. With margins currently expanding, we let the steady-state level sit near recent peak performance – but no higher.
- Revenue at maturity: $14.4B of net income at 30.3% margin implies a revenue base of $47.5B, up from $21.7B today.
- Required revenue CAGR: 21.7% annually for the next 4 years.
Is This Realistic?
Here is the surprise: LRCX grew at 26.5% last year, but the valuation only needs 21.7% over the next 4 years. In other words, the market has already priced in a meaningful slowdown from the current pace. If LRCX can hold anywhere close to today’s growth rate, the math works comfortably. The risk here is not the valuation – it is whether the business deteriorates faster than the multiple already implies.
The scale check. $47.5B of revenue would put LRCX at about 1.7x the revenue of AMAT, currently the largest peer – the math requires LRCX to leapfrog the entire competitive set. LRCX’s current revenue is $21.7B, so the multiple is implicitly asking for a roughly 2.2x revenue expansion over 4 years. Companies do leapfrog industry leaders, but rarely – and usually only when they are riding a structurally new market the incumbents cannot serve. That is the bet baked into the price.
One thing to flag: the implied margin of 30.3% is at or near LRCX’s recent peak. Sustaining peak margins through a maturing phase is not the base case for most businesses; if margins fade toward the 3-year average instead, the required revenue growth would need to be even higher than 21.7%.
LRCX has retired roughly 7.4% of its share count over the last 3 years. If buybacks continue at a similar pace, the per-share math is easier than the absolute net income math – though the absolute market cap requirement does not change.
None of this is a price target. It is the implicit story the multiple is telling. The bet is, oddly, on LRCX not deteriorating sharply. If growth holds anywhere near the current pace, the stock is doing more than the multiple demands.
Should You Invest?
Reverse-engineering the growth baked into today’s high multiples reveals a thin margin for error. A single-stock thesis at these valuations is inherently fragile. As historical volatility shows, relying on the “priced-for-perfection” math of one position ignores the structural risk that high-multiple names face during broader market inflections. The solution? A rule-based portfolio approach.
The Trefis High Quality (HQ) Portfolio combines analytical rigor with a forward-looking view across 30 stocks, with a consistent selection framework and a sizing and rebalancing discipline designed to deliver upside without the single-name risk you just read through here.
By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000.